Clinical Trial Update: European Drug Utilization Study

View source ↗

Summary

This document reports the completion of a European drug utilization study sponsored by AstraZeneca evaluating use patterns for Major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder (MDD) | Status: COMPLETED